Biocon Biologics Ltd. has received FDA approval for its denosumab biosimilars, Bosaya and Aukelso, marking a major milestone in expanding affordable biologic therapies in the U.S.
Lupin, a pharmaceutical company based in Mumbai, announced on Wednesday that the US Food and Drug Administration (US FDA) had approved a generic version of Lenalidomide capsules in many strengths, including 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25
HCG Manavata Cancer Centre (HCGMCC) confirms its dedication to fighting prostate cancer, one of the most common cancers among men in India, as the globe recognizes prostate cancer awareness month this September
In order to transform healthcare concepts into significant, market-ready solutions, the Andhra Pradesh MedTech Zone (AMTZ) has introduced the Innovation Passport (i-Passport), a unique single-access gateway.
The government has planned for a Promotion of Research and Innovation in Pharma MedTech (PRIP) scheme to be rolled out this month.
Cadila Pharmaceuticals, research-driven pharmaceutical company, one of the best in India, has launched Nu Nutridac, a clinically validated dietary supplement specially designed to relieve the patients
Dr Reddy's Laboratories has revealed that the India launch of Tegoprazan (50 mg) will be available shortly. It is a new generation potassium-competitive acid blocker (P-CAB) created to treat acid-related gastrointestinal disorders.
The World Health Organization (WHO) has introduced the updated guidelines that focus on strengthening HIV service provision, on improving long-term adherence to antiretroviral therapy (ART), and on promoting the overall health
A key equity stake in its subsidiary and a major investment in a new state-of-the-art oncology facility have been announced by Apollo Hospitals Enterprise Ltd (AHEL) as a significant strategic move.
Novo Nordisk plans to venture further into obesity therapeutics to determine whether its next-generation weight-loss drug will also successfully address a myriad of health conditions related to obesity...